U.S. flag

An official website of the United States government

NM_001077365.2(POMT1):c.1727T>C (p.Val576Ala) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000687622.6

Allele description [Variation Report for NM_001077365.2(POMT1):c.1727T>C (p.Val576Ala)]

NM_001077365.2(POMT1):c.1727T>C (p.Val576Ala)

Gene:
POMT1:protein O-mannosyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.13
Genomic location:
Preferred name:
NM_001077365.2(POMT1):c.1727T>C (p.Val576Ala)
HGVS:
  • NC_000009.12:g.131521374T>C
  • NG_008896.1:g.23473T>C
  • NM_001077365.2:c.1727T>CMANE SELECT
  • NM_001077366.2:c.1565T>C
  • NM_001136113.2:c.1727T>C
  • NM_001136114.2:c.1376T>C
  • NM_001353193.2:c.1793T>C
  • NM_001353194.2:c.1565T>C
  • NM_001353195.2:c.1376T>C
  • NM_001353196.2:c.1637T>C
  • NM_001353197.2:c.1631T>C
  • NM_001353198.2:c.1631T>C
  • NM_001353199.2:c.1442T>C
  • NM_001353200.2:c.1271T>C
  • NM_001374689.1:c.1715T>C
  • NM_001374690.1:c.1508T>C
  • NM_001374691.1:c.1376T>C
  • NM_001374692.1:c.1376T>C
  • NM_001374693.1:c.1376T>C
  • NM_001374695.1:c.1337T>C
  • NM_007171.4:c.1793T>C
  • NP_001070833.1:p.Val576Ala
  • NP_001070834.1:p.Val522Ala
  • NP_001129585.1:p.Val576Ala
  • NP_001129586.1:p.Val459Ala
  • NP_001340122.2:p.Val598Ala
  • NP_001340123.1:p.Val522Ala
  • NP_001340124.1:p.Val459Ala
  • NP_001340125.1:p.Val546Ala
  • NP_001340126.2:p.Val544Ala
  • NP_001340127.2:p.Val544Ala
  • NP_001340128.2:p.Val481Ala
  • NP_001340129.1:p.Val424Ala
  • NP_001361618.1:p.Val572Ala
  • NP_001361619.1:p.Val503Ala
  • NP_001361620.1:p.Val459Ala
  • NP_001361621.1:p.Val459Ala
  • NP_001361622.1:p.Val459Ala
  • NP_001361624.1:p.Val446Ala
  • NP_009102.3:p.Val598Ala
  • NP_009102.4:p.Val598Ala
  • LRG_842t1:c.1793T>C
  • LRG_842t2:c.1727T>C
  • LRG_842p1:p.Val598Ala
  • LRG_842p2:p.Val576Ala
  • NC_000009.11:g.134396761T>C
  • NM_007171.3:c.1793T>C
  • NR_148391.2:n.1761T>C
  • NR_148392.2:n.1979T>C
  • NR_148393.2:n.1900T>C
  • NR_148394.2:n.1654T>C
  • NR_148395.2:n.2052T>C
  • NR_148396.2:n.1686T>C
  • NR_148397.2:n.1811T>C
  • NR_148398.2:n.1766T>C
  • NR_148399.2:n.2292T>C
  • NR_148400.2:n.1891T>C
Protein change:
V424A
Links:
dbSNP: rs144338642
NCBI 1000 Genomes Browser:
rs144338642
Molecular consequence:
  • NM_001077365.2:c.1727T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001077366.2:c.1565T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001136113.2:c.1727T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001136114.2:c.1376T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353193.2:c.1793T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353194.2:c.1565T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353195.2:c.1376T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353196.2:c.1637T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353197.2:c.1631T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353198.2:c.1631T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353199.2:c.1442T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353200.2:c.1271T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374689.1:c.1715T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374690.1:c.1508T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374691.1:c.1376T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374692.1:c.1376T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374693.1:c.1376T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374695.1:c.1337T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007171.4:c.1793T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148391.2:n.1761T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148392.2:n.1979T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148393.2:n.1900T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148394.2:n.1654T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148395.2:n.2052T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148396.2:n.1686T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148397.2:n.1811T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148398.2:n.1766T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148399.2:n.2292T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_148400.2:n.1891T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Autosomal recessive limb-girdle muscular dystrophy type 2K
Synonyms:
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; Limb-girdle muscular dystrophy-dystroglycanopathy, type C1
Identifiers:
MONDO: MONDO:0012248; MedGen: C1836373; Orphanet: 86812; OMIM: 609308
Name:
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 (MDDGB1)
Synonyms:
MUSCULAR DYSTROPHY, CONGENITAL, POMT1-RELATED; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 1
Identifiers:
MONDO: MONDO:0013159; MedGen: C5436962; OMIM: 613155
Name:
Walker-Warburg congenital muscular dystrophy
Synonyms:
Muscular dystrophy-dystroglycanopathy, type A; Walker-Warburg syndrome
Identifiers:
MONDO: MONDO:0000171; MedGen: C0265221; Orphanet: 899; OMIM: PS236670

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000815201Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Sep 13, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000815201.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 598 of the POMT1 protein (p.Val598Ala). This variant is present in population databases (rs144338642, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with POMT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 260143). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POMT1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024